Maximilian Kopp
Impact in
-
- Diabetes Treatment and Management
-
- Advanced Glycation End Products research
Papers in
-
- Receptor Mechanisms and Signaling 2
- Ion channel regulation and function 1
-
- Diabetes Treatment and Management 3
- Co-authors
- Swenja Kröller‐Schön (5 shared papers)Andreas Daiber (6 shared papers)Thomas Münzel (6 shared papers)Sebastian Steven (5 shared papers)Matthias Oelze (6 shared papers)Philip Wenzel (3 shared papers)Siyer Roohani (3 shared papers)F. Ravandi Kashani (3 shared papers)
In The Last Decade
Maximilian Kopp
8 papers receiving 407 citations
Peers
Comparison fields: 5 of 71
- Endocrinology, Diabetes and Metabolism 226
- Clinical Biochemistry 29
- Physiology 87
- Cardiology and Cardiovascular Medicine 75
- Surgery 129
Countries citing papers authored by Maximilian Kopp
This map shows the geographic impact of Maximilian Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Kopp more than expected).
Fields of papers citing papers by Maximilian Kopp
This network shows the impact of papers produced by Maximilian Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Kopp. The network helps show where Maximilian Kopp may publish in the future.
Co-authors
The 25 scholars most cited alongside Maximilian Kopp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 243 | |
| 2 | 2016 | 83 | |
| 3 | 1989 | 46 | |
| 4 | 2015 | 28 | |
| 5 | 2015 | 7 | |
| 6 | 2019 | 6 | |
| 7 | 2017 | 6 | |
| 8 | 2017 | 1 |
About Maximilian Kopp
Maximilian Kopp is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Physiology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 420 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Receptor Mechanisms and Signaling (2 papers), Cardiac Imaging and Diagnostics (2 papers), Pancreatic function and diabetes (1 paper), Ion channel regulation and function (1 paper), Laser-induced spectroscopy and plasma (1 paper) and Pain Mechanisms and Treatments (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (226 citations), Clinical Biochemistry (29 citations), Physiology (87 citations), Cardiology and Cardiovascular Medicine (75 citations) and Surgery (129 citations). Maximilian Kopp has collaborated with scholars based in Germany, France and Austria. Frequent co-authors include Swenja Kröller‐Schön, Andreas Daiber, Thomas Münzel, Sebastian Steven, Matthias Oelze, Philip Wenzel, Siyer Roohani, F. Ravandi Kashani, Philipp Welschof and Eberhard Schulz. Their work appears in journals such as Pharmacology, Brain Research, Vascular Pharmacology, British Journal of Pharmacology and Redox Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.